Therapy for dermatomyositis and polymyositis.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D002114:Calcinosis / Q000209:etiology; D002648:Child; D003882:Dermatomyositis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009136:Muscular Dystrophies / Q000175:diagnosis; D009220:Myositis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D009369:Neoplasms / Q000150:complications; D013577:Syndrome; D009626:Terminology as Topic
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents